Top news of the week: 20.12.2022.
Ginkgo Has Hired A New Head Of Biopharma To Disrupt The Gene And Cell Therapies Market
Cell therapies save lives but can cost millions of dollars because of how slow and inefficient pharma R&D is. What if cell engineering was outsourced to synbio companies like Ginkgo that ...
33 healthcare and biotech startups investors expect to take off in 2023
We asked investors to name the startups poised for success in a tough market, from young upstarts to companies on the brink of going public.
Fujifilm’s Life Sciences Corporate Venture Capital Fund Invests in PhenoVista Biosciences
PhenoVista Biosciences (PhenoVista), a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay
Nimbus CEO Jeb Keiper on negotiating a $4B deal and building an unorthodox biotech startup
Days after inking one of the largest deals for an unapproved drug, the CEO spoke with BioPharma Dive about the company’s unusual origins and decision to remain private — for now.
Elemental Machines Is Bringing The Internet Of Things To Lab Operations To Save Millions Of Dollars For Biotech Companies
What if you could control your biotech lab space remotely? This is no longer a fantasy: Elemental is bringing the Internet of Things to lab ops to potentially save millions of dollars for ...
Big Pharma will find right formula for M&A binge
Drugmakers are primed for a shopping spree in 2023. Companies like Pfizer and GSK are in relatively rude health, thanks to bumper sales from vaccines and a post-pandemic recovery in cancer ...
Moderna's CEO predicts how the biotech's work in cancer vaccines could transform healthcare, starting with your annual physical
Plotting the next act beyond COVID-19, Moderna CEO Stephane Bancel told Insider his vision for mRNA cancer vaccines.
What We Got Right And Wrong In Our 2022 AI Predictions
5 correct predictions, 3 incorrect predictions, 2 tossups. Not bad!